PromoCell

PromoCell We are a leading biotechnology company who supports scientists worldwide with high-end human cell cul

At PromoCell, we help scientists do better research with a world-class portfolio of human primary, stem and blood cells as well as optimized cell culture media. With over 30 years of expertise, we are recognized globally for supplying scientists with the tools and support they need to do groundbreaking research. All our products comply with European biomedical conventions, ensuring human rights an

d donor privacy are always protected. Our ISO certifications demonstrate our absolute commitment to quality and our EXCiPACT™ GMP certification enables us to produce our cell culture media and reagents according to GMP standards as a manufacturer of pharmaceutical excipients. Each year 600 peer-reviewed publications feature PromoCell products. We operate in over 40 countries around the world, helping scientists with all of their research needs.

What distinguishes a research-stage stem cell workflow from one that's ready for clinical translation? It's not just abo...
02/06/2026

What distinguishes a research-stage stem cell workflow from one that's ready for clinical translation?
It's not just about the science. It's about robustness, traceability, scalability, and thinking about your end application from day one. Dr. Hagen Wieland, our R&D Team Lead, explains why the decisions you make early matter.

Read the expert interview on RegMedNet: https://eu1.hubs.ly/H0vvlLv0

Bone is one of the most vascularized tissues in the body, yet there’s a lack of in vitro systems that accurately mimic b...
28/05/2026

Bone is one of the most vascularized tissues in the body, yet there’s a lack of in vitro systems that accurately mimic both bone formation and vascularization. How do you engineer a model that incorporates both processes without sacrificing cell viability or differentiation quality?

In a study published in Advanced Materials Interfaces, Teixeira et al. developed small pre-vascularized spheroids (around 250 cells each) using human mesenchymal stem cells (hMSCs) or human periosteum-derived stem cells (hPDCs), co-cultured with human umbilical vein endothelial cells (HUVECs).
The study showed that both hMSC and hPDC spheroids formed stable structures and underwent osteogenic differentiation while supporting endothelial patterning seen in native vascular structures. The spheroids lacked necrotic cores, which are often observed in large spheroids. By working with low-cell-density, small-diameter spheroids, the team developed viable, structurally stable spheroids with functional features relevant to bone models.

Studies using well-characterized human primary cells, such as our hMSCs, can provide building blocks for more biomimetic bone tissue models and future 3D bioprinting applications.

Teixeira FC, Joris V, van Griensven M, et al. Pre-vascularized hMSC and hPDC spheroids as building block units for bone tissue engineering. Advanced Materials Interfaces. 2026;13:e00804. https://eu1.hubs.ly/H0vvg_z0

26/05/2026

Freezing cells isn’t the hard part, bringing them back to life is.
During cryopreservation, sensitive cells, such as stem cells, face multiple stressors, from ice crystal formation to osmotic shock.
These challenges can compromise membrane integrity, metabolism, and long-term functionality after thawing. Understanding where things go wrong is the first step toward better recovery rates.

Read our blog to explore the most common cryopreservation pitfalls—and how to avoid them: https://eu1.hubs.ly/H0vwKkw0

Stem cell therapy development is advancing, but moving from research to clinical-grade manufacturing can be challenging....
21/05/2026

Stem cell therapy development is advancing, but moving from research to clinical-grade manufacturing can be challenging.
In a new In Focus feature on Reg Med Net - the Regenerative Medicine Network, Dr. Hagen Wieland shares his perspective on building translation-ready workflows. The feature also includes an infographic that maps the steps for building reproducible and scalable workflows.

Access the In Focus feature on RegMedNet: https://eu1.hubs.ly/H0vvl8_0

What an inspiring few days at ISCT 2026 in Dublin!Thank you to everyone who stopped by our booth and took the time to co...
13/05/2026

What an inspiring few days at ISCT 2026 in Dublin!

Thank you to everyone who stopped by our booth and took the time to connect with us. It was a pleasure meeting so many passionate scientists and industry experts and discussing the future of cell and gene therapy.

The conversations around our Custom GMP Services and PromoExQ solutions were truly energizing and reinforced our commitment to supporting your therapeutic development goals.

To everyone we met, we look forward to continuing the conversation. And if we didn’t get a chance to connect, it’s never too late.
Reach out to learn how we can support your next project or visit our website to explore our GMP offerings: https://eu1.hubs.ly/H0vcW_X0

Day 1 at ISCT 2026 is officially underway!We’re happy to be in Dublin, connecting with the global cell and gene therapy ...
06/05/2026

Day 1 at ISCT 2026 is officially underway!
We’re happy to be in Dublin, connecting with the global cell and gene therapy community.

Our team is on‑site and ready to discuss how our Custom GMP Services can support your manufacturing strategy and how our PromoExQ portfolio delivers reliable, off‑the‑shelf solutions for your research and clinical programs.

Stop by booth #1708 to meet our experts Lucía Cespón and Iris Bischoff-Kont.

Short on time? You can already book a 1:1 on-site meeting here: https://meetings-eu1.hubspot.com/lucia-cespon/isct-meeting-scheduling-page

Counting down to ISCT 2026 in Dublin – Are you attending? To make the most of your visit, you can now book a dedicated t...
04/05/2026

Counting down to ISCT 2026 in Dublin – Are you attending?
To make the most of your visit, you can now book a dedicated time slot to meet our experts in person at booth #1708.
Book your time slot here: https://eu1.hubs.ly/H0tZSXC0

Connect with Lucía Cespón and Iris Bischoff-Kont to discuss your cell therapy projects, from early research to GMP manufacturing.
See you soon at ISCT!

30/04/2026

Cancer stem cells (CSCs) aren’t locked into one state.
The plasticity of CSCs enables them to switch between stem-like and differentiated states based on the environment. Their plasticity is influenced by external factors like inflammation and tissue damage, genetic changes, and pressure from treatments.
CSC plasticity can complicate the development of CSC-targeting therapies.
At the same time, understanding CSC transitions could unlock new therapeutic approaches and explain treatment resistance.

Learn more about CSC plasticity and its implications: https://eu1.hubs.ly/H0syTfh0

Heading to Dublin for ISCT 2026We’re excited to attend the ISCT, International Society for Cell & Gene Therapy Annual Me...
28/04/2026

Heading to Dublin for ISCT 2026
We’re excited to attend the ISCT, International Society for Cell & Gene Therapy Annual Meeting, taking place May 6–9 in Dublin, Ireland.

Join us and meet our experts, Lucía Cespón and Iris Bischoff-Kont. We’ll be showcasing our Custom GMP Services and PromoExQ off‑the‑shelf solutions, designed to support your therapeutic development from early research through clinical manufacturing.

Visit us at booth #1708 – Let’s connect to discuss your projects, and how we can help accelerate your path to the clinic.
Stay tuned for more updates from Dublin.

Adresse

SickingenStr. 63/65
Heidelberg
69126

Öffnungszeiten

Montag 08:30 - 17:00
Dienstag 08:30 - 17:00
Mittwoch 08:30 - 17:00
Donnerstag 08:30 - 17:00
Freitag 08:30 - 17:00

Telefon

+496221649340

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von PromoCell erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Service Kontaktieren

Nachricht an PromoCell senden:

Teilen